Annals of Clinical Neurophysiology

The Korean Society of Clinical Neurophysiology (대한임상신경생리학회)
권호 표지
DOI QR코드

DOI QR Code

Adrenomyeloneuropathy with cerebral involvement due to a novel frameshift variant in ABCD1 gene

  • Kim, Hye Weon (Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Hyunjin (Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Jeong, Dongyoung (Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Chung, Kyuyoon (Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Lee, Eun-Jae (Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Lim, Young-Min (Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Kwang-Kuk (Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine)
  • Received : 2021.01.19
  • Accepted : 2021.03.10
  • Published : 2021.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Adrenoleukodystrophy (ALD) is the most common peroxisomal disorder caused by mutations in the gene, ABCD1, causing abnormal accumulation of very-long-chain fatty acids in the nervous system and adrenal glands. There are various clinical manifestations of ALD. Here we report a 47-year-old male with adrenomyeloneuropathy with cerebral involvement who exhibited progressive gait disturbance and cognitive impairment. A novel frameshift variant (c.95del [p.Val32Alafs*36]) in exon 1 of ABCD1 was identified. This report provides additional information regarding the various clinical characteristics of ALD.

Keywords

References

  1. Mosser J, Douar AM, Sarde CO, Kioschis P, Feil R, Moser H, et al. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 1993;361:726-730. https://doi.org/10.1038/361726a0
  2. Boehm CD, Cutting GR, Lachtermacher MB, Moser HW, Chong SS. Accurate DNA-based diagnostic and carrier testing for X-linked adrenoleukodystrophy. Mol Genet Metab 1999;66:128-136. https://doi.org/10.1006/mgme.1998.2779
  3. Pavlakis SG. New insights into adrenoleukodystrophy. Eur J Paediatr Neurol 2017;21:597. https://doi.org/10.1016/j.ejpn.2017.05.002
  4. Kemp S, Huffnagel IC, Linthorst GE, Wanders RJ, Engelen M. Adrenoleukodystrophy-neuroendocrine pathogenesis and redefinition of natural history. Nat Rev Endocrinol 2016;12:606-615. https://doi.org/10.1038/nrendo.2016.90
  5. Berger J, Forss-Petter S, Eichler FS. Pathophysiology of X-linked adrenoleukodystrophy. Biochimie 2014;98:135-142. https://doi.org/10.1016/j.biochi.2013.11.023
  6. Park HJ, Shin HY, Kang HC, Choi BO, Suh BC, Kim HJ, et al. Clinical and genetic aspects in twelve Korean patients with adrenomyeloneuropathy. Yonsei Med J 2014;55:676-682. https://doi.org/10.3349/ymj.2014.55.3.676
  7. Vanderver A. Genetic leukoencephalopathies in adults. Continuum (Minneap Minn) 2016;22:916-942. https://doi.org/10.1212/con.0000000000000338
  8. Kohler W, Curiel J, Vanderver A. Adulthood leukodystrophies. Nat Rev Neurol 2018;14:94-105. https://doi.org/10.1038/nrneurol.2017.175
  9. Eichler F, Duncan C, Musolino PL, Orchard PJ, De Oliveira S, Thrasher AJ, et al. Hematopoietic stem-cell gene therapy for cerebral adrenoleukodystrophy. N Engl J Med 2017;377:1630-1638. https://doi.org/10.1056/NEJMoa1700554
  10. Gong Y, Mu D, Prabhakar S, Moser A, Musolino P, Ren J, et al. Adenoassociated virus serotype 9-mediated gene therapy for x-linked adrenoleukodystrophy. Mol Ther 2015;23:824-834. https://doi.org/10.1038/mt.2015.6